Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikiko Ohno

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Cardiovascular Medicine|February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancerShu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Neuron|December 27, 2016
Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and NeurodegenerationWan Hee Yoon, Hector Sandoval, Sonal Nagarkar-Jaiswal, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 1, 2026
Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC studyKazumasa Yamagishi, Takaki Hiwasa, Wanlu Sun, et al.
Cancer Science|September 17, 2020
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseasesMakoto Sumazaki, Hideaki Shimada, Masaaki Ito, et al.
Oncotarget|February 22, 2018
Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarctionHao Wang, Xiao-Meng Zhang, Go Tomiyoshi, et al.
BMC Medicine|June 9, 2021
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic strokeTakaki Hiwasa, Hao Wang, Ken-Ichiro Goto, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Frontiers in Cardiovascular Medicine|February 27, 2023
Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancerShu-Yang Li, Yoichi Yoshida, Masaaki Kubota, et al.
Neuron|December 27, 2016
Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and NeurodegenerationWan Hee Yoon, Hector Sandoval, Sonal Nagarkar-Jaiswal, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 1, 2026
Plasma autoantibodies as novel risk markers for stroke: A nested case-control study of the JPHC studyKazumasa Yamagishi, Takaki Hiwasa, Wanlu Sun, et al.
Cancer Science|September 17, 2020
Serum anti-LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseasesMakoto Sumazaki, Hideaki Shimada, Masaaki Ito, et al.
Oncotarget|February 22, 2018
Association of serum levels of antibodies against MMP1, CBX1, and CBX5 with transient ischemic attack and cerebral infarctionHao Wang, Xiao-Meng Zhang, Go Tomiyoshi, et al.
BMC Medicine|June 9, 2021
Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic strokeTakaki Hiwasa, Hao Wang, Ken-Ichiro Goto, et al.
Pageof 4